DIO: Enzyme Immunoassay, Cocaine And Cocaine Metabolites

Product code DIO, “Enzyme Immunoassay, Cocaine And Cocaine Metabolites” in FDA's classification database, is a Class II device type under 21 CFR 862.3250 (cocaine and cocaine metabolite test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 145 clearances under DIO, 26 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
DIO
Regulation
21 CFR 862.3250
Class
II
Panel
Clinical Toxicology
Clearances
145
Most recent
Jan 27, 2022
Third-party review
Eligible
Implant
No

What it covers

A cocaine and cocaine metabolite test system is a device intended to measure cocaine and a cocaine metabolite (benzoylecgonine) in serum, plasma, and urine. Measurements obtained by this device are used in the diagnosis and treatment of cocaine use or overdose.

The identification in 21 CFR 862.3250, cocaine and cocaine metabolite test system. FDA gives DIO no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K213211Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Enzyme Immunoassay (COCM) Test SystemCarolina Liquid Chemistries Corp.Jan 27, 2022Traditional
K211973DRI Cocaine Metabolite AssayMicrogenics CorporationSep 24, 2021Traditional
K191638Pointe Scientific Cocaine Metabolite Enzyme ImmunoassayMedtest DXMar 12, 2020Traditional
K181499DRI Cocaine Metabolite AssayMicrogenics CorporationJul 6, 2018Traditional
K170293Emit II Plus Cocaine Metabolite AssaySiemens Healthcare Diagnostics, Inc.Oct 25, 2017Traditional
K163570Carolina Liquid Chemistries Cocaine and Cocaine Metabolite Test System (COCM)Carolina Liquid Chemistries CorporationAug 15, 2017Traditional
K162395MP DOA-10 Panel Test Cup, MP DOA-11 Panel Test CupMp Biomedicals, LLCJun 2, 2017Special
K152232Quest Diagnostics HairCheck-DT (Cocaine)Quest Diagnostics IncorporatedNov 18, 2016Traditional
K161214Wondfo Amphetamine Urine Test AMP 500 (Cup, Dipcard), Wondfo Cocaine Urine Test COC 150(Cup, Dipcard), Wondfo Methamphetamine Urine Test MET 500 (Cup, Dipcard)Guangzhou Wondfo Biotech Co., Ltd.Jun 27, 2016Traditional
K153646SAFECARE Urine Test Amphetamine, SAFECARE Urine Test Cocaine, SAFECARE Urine Test MarijuanaSafecare Biotech (Hangzhou) Co., Ltd.Mar 18, 2016Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 145 with a free account)

Clearances by year

26 DIO 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
20221120
2021191
20201267
2018129
20173267
2016388
20152219
2014238
20132126
20125139
2011565

Who submits

21 applicants cleared a DIO device since 2011. 88% of the clearances went to applicants in United States, then China (8%) and United Kingdom (4%). By type: Traditional 88% and Special 12%.

ApplicantClearances since 2011
Guangzhou Wondfo Biotech Co., Ltd.4
Microgenics Corporation2
Omega Laboratories, Inc.2
Ameditech, Inc.1
Biophor Diagnostics, Inc.1
Branan Medical Corporation1
Carolina Liquid Chemistries Corp.1
Carolina Liquid Chemistries Corporation1

How FDA classifies it

Class II (special controls). A cocaine and cocaine metabolite test system is not exempt if it is intended for any use other than employment or insurance testing. The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9, provided the test system is intended for employment and insurance testing and includes a statement in the labeling that the device is intended solely for use in employment and insurance testing.

From 21 CFR 862.3250. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 862.3250 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DIO clearances declared.

Ask about DIO

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about DIO

What is FDA product code DIO?

Product code DIO, “Enzyme Immunoassay, Cocaine And Cocaine Metabolites” in FDA's classification database, is a Class II device type under 21 CFR 862.3250 (cocaine and cocaine metabolite test system), reviewed by FDA's Clinical Toxicology panel. FDA's 510(k) database lists 145 clearances under DIO, 26 of them since 2011.

How many 510(k) clearances are there under DIO?

FDA’s 510(k) database listed 145 clearances under DIO as of Oct 29, 2026, 26 of them decided since 2011; the most recent decision was Jan 27, 2022. The Predicate Finder searches the live database.

Which companies have the most DIO clearances?

Since 2011: Guangzhou Wondfo Biotech Co., Ltd. (4), Microgenics Corporation (2), Omega Laboratories, Inc. (2), Ameditech, Inc. (1) and Biophor Diagnostics, Inc. (1). 21 applicants have cleared a DIO device in that time.

Sources

  1. FDA product classification: DIO · Product Classification database
  2. 21 CFR 862.3250: Cocaine and cocaine metabolite test system · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for DIO · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow DIOGet an email when FDA clears, recalls or publishes guidance for DIO devices.

Know what FDA already cleared.